Fluphenazine, an antipsychotic compound, ameliorates Alzheimer's disease by clearing amyloid beta accumulation in C. elegans
Mayur Nimbadas Devare, Victoria Le, Vanessa Chung, T. J. Vu, Matt R. Kaeberlein
This study screens FDA-approved compounds in yeast and C. elegans to identify potential Alzheimer's disease treatments, finding that fluphenazine reduces amyloid-beta accumulation.
GeroScience · Sep 9, 2025Peer-reviewedMolecular Biology